Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Nature Reviews. Immunology
|
April 7, 2020
Dysregulation of lung myeloid cells in COVID-19
Bérengère Salomé, Assaf Magen
Plos Computational Biology
|
December 1, 2017
A network diffusion approach to inferring sample-specific function reveals functional changes associated with breast cancer
Sushant Patkar, Assaf Magen, Roded Sharan, et al.
Cell Reports
|
December 5, 2019
Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4<sup>+</sup> T Cells
Assaf Magen, Jia Nie, Thomas Ciucci, et al.
Cell Reports
|
July 25, 2019
Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in Cancer
Assaf Magen, Avinash Das Sahu, Joo Sang Lee, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
January 26, 2021
A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19
Daniel Geanon, Brian Lee, Edgar Gonzalez-Kozlova, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2024
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumors
Samarth Hegde, Bruno Giotti, Brian Y Soong, et al.
Nature
|
September 10, 2025
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours
Samarth Hegde, Bruno Giotti, Brian Y Soong, et al.
Nature Immunology
|
April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Matthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Nature Communications
|
February 6, 2025
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
Shivan Sivakumar, Ashwin Jainarayanan, Edward Arbe-Barnes, et al.
The Lancet. Gastroenterology & Hepatology
|
January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Thomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Nature Reviews. Immunology
|
April 7, 2020
Dysregulation of lung myeloid cells in COVID-19
Bérengère Salomé, Assaf Magen
Plos Computational Biology
|
December 1, 2017
A network diffusion approach to inferring sample-specific function reveals functional changes associated with breast cancer
Sushant Patkar, Assaf Magen, Roded Sharan, et al.
Cell Reports
|
December 5, 2019
Single-Cell Profiling Defines Transcriptomic Signatures Specific to Tumor-Reactive versus Virus-Responsive CD4<sup>+</sup> T Cells
Assaf Magen, Jia Nie, Thomas Ciucci, et al.
Cell Reports
|
July 25, 2019
Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in Cancer
Assaf Magen, Avinash Das Sahu, Joo Sang Lee, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
January 26, 2021
A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19
Daniel Geanon, Brian Lee, Edgar Gonzalez-Kozlova, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2024
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumors
Samarth Hegde, Bruno Giotti, Brian Y Soong, et al.
Nature
|
September 10, 2025
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours
Samarth Hegde, Bruno Giotti, Brian Y Soong, et al.
Nature Immunology
|
April 20, 2023
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Matthew D Park, Ivan Reyes-Torres, Jessica LeBerichel, et al.
Nature Communications
|
February 6, 2025
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
Shivan Sivakumar, Ashwin Jainarayanan, Edward Arbe-Barnes, et al.
The Lancet. Gastroenterology & Hepatology
|
January 22, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Thomas U Marron, Maria Isabel Fiel, Pauline Hamon, et al.
Page
of 2